WOUND MANAGEMENT TECHNOLOGIES, INC. (28)

Browse by Contract Category

Contracts

Separation Agreement and General Release and Waiver, dated December 2, 2022, between Sanara MedTech Inc. and Shawn M. Bowman (Filed With SEC on December 6, 2022)
Membership Interest Purchase Agreement, dated July 1, 2022, by and among Sanara MedTech Inc., Scendia Biologics, LLC and Ryan Phillips (Filed With SEC on July 5, 2022)
Agreement and Plan of Merger, dated April 1, 2022, by and among Sanara MedTech Inc., United Wound and Skin Solutions, LLC, Precision Healing Inc., PH Merger Sub I, Inc., PH Merger... (Filed With SEC on April 4, 2022)
Description of Securities (Filed With SEC on March 30, 2021)
Amendment No. 1 to Exclusive License Agreement dated July 7, 2019 with Rochal Industries, LLC (Filed With SEC on November 13, 2020)
Employment Agreement, dated April 28, 2022, by and between Sanara MedTech Inc. and Michael D. McNeil (Filed With SEC on April 29, 2022)
Amended and Restated Employment Agreement, dated April 28, 2022, by and between Sanara MedTech Inc. and Zachary B. Fleming (Filed With SEC on April 29, 2022)
Precision Healing Inc. 2020 Stock Option and Grant Plan (Filed With SEC on April 8, 2022)
Common Stock Warrant, issued by Sanara MedTech Inc. to Furneaux Capital Holdco, LLC (d/b/a BlueIO) on April 4, 2022 (Filed With SEC on April 8, 2022)
Common Stock Warrant, issued by Sanara MedTech Inc. to Furneaux Capital Holdco, LLC (d/b/a BlueIO) on April 4, 2022 (Filed With SEC on April 8, 2022)
Retirement Agreement, dated December 22, 2021, between Sanara MedTech Inc. and J. Michael Carmena (Filed With SEC on December 22, 2021)
Modification Agreement to Loan Agreement, dated January 15, 2021, between the Company, as Borrower, and Cadence Bank, N.A, as Lender (Filed With SEC on August 16, 2021)
Consulting Agreement, dated July 14, 2021, by and between Sanara MedTech Inc. and Ann Beal Salamone (Filed With SEC on July 19, 2021)
Asset Purchase Agreement, dated July 14, 2021, by and between Sanara MedTech Inc., as Purchaser, and Rochal Industries, LLC, as Seller (Filed With SEC on July 19, 2021)
Form of Restricted Stock Award Agreement under the Sanara MedTech Inc. Restated 2014 Omnibus Long-Term Incentive Plan (Filed With SEC on March 30, 2021)
Underwriting Agreement, dated February 12, 2021, by and between Sanara MedTech Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 17, 2021)
Second Amendment of Sublicense Agreement, dated January 26, 2021, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)
First Amendment of Sublicense Agreement, dated May 31, 2019, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)
Sublicense Agreement, dated August 27, 2018, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)
Loan Agreement, dated January 15, 2021, between the Company, as Borrower, and Cadence Bank, N.A, as Lender (Filed With SEC on January 22, 2021)
Product License Agreement effective May 4, 2020 (Filed With SEC on May 12, 2020)
Promissory Note dated April 22, 2020 (Filed With SEC on April 29, 2020)
Employment Agreement dated June 1, 2019 between Sanara MedTech Inc. and Zachary B. Fleming (Filed With SEC on March 26, 2020)
Employment Agreement dated June 1, 2019 between Sanara MedTech Inc. and Shawn M. Bowman (Filed With SEC on March 26, 2020)
Exclusive License Agreement dated October 1, 2019 between Sanara MedTech Inc. and Rochal Industries, LLC (Filed With SEC on November 14, 2019)
Exclusive License Agreement dated July 7, 2019 between Sanara MedTech Inc. and Rochal Industries, LLC (Filed With SEC on August 14, 2019)
Series F Preferred Stock Certificate of Designations (Filed With SEC on March 21, 2019)
Share Exchange Agreement (Filed With SEC on March 21, 2019)